相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Local coordination between intracortical bone remodeling and vascular development in human juvenile bone
Christina Moller Andreasen et al.
BONE (2023)
Alendronate prolongs the reversal-resorption phase in human cortical bone remodeling
Xenia G. Borggaard et al.
BONE (2022)
Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites
Xenia G. Borggaard et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism
Barbara C. Silva et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
The generation of enlarged eroded pores upon existing intracortical canals is a major contributor to endocortical trabecularization
Christina Moller Andreasen et al.
BONE (2020)
Re-thinking the bone remodeling cycle mechanism and the origin of bone loss
Jean-Marie Delaisse et al.
BONE (2020)
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
Michael Mannstadt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Understanding Age-Induced Cortical Porosity in Women: The Accumulation and Coalescence of Eroded Cavities Upon Existing Intracortical Canals Is the Main Contributor
Christina Moller Andreasen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry
Mishaela R. Rubin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Understanding age-induced cortical porosity in women: Is a negative BMU balance in quiescent osteons a major contributor?
Christina M. Andreasen et al.
BONE (2018)
Physiology of Parathyroid Hormone
David Goltzman
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Tethering Formation to Resorption: Reversal Revisited
David W. Dempster
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Coupling of Bone Resorption and Formation in Real Time: New Knowledge Gained From Human Haversian BMUs
Nicolai Ernlund Lassen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Parathyroid hormone 1-34 and skeletal anabolic action THE USE OF PARATHYROID HORMONE IN BONE FORMATION
L. Osagie-Clouard et al.
BONE & JOINT RESEARCH (2017)
Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts
Mohamed Essameldin Abdelgawad et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
Effects of Daily or Cyclic Teriparatide on Bone Formation in the Iliac Crest in Women on No Prior Therapy and in Women on Alendronate
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Effect of Teriparatide on Bone Formation in the Human Femoral Neck
Felicia Cosman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report
Atsushi Nishikawa et al.
CLINICAL INTERVENTIONS IN AGING (2016)
A joined role of canopy and reversal cells in bone remodeling - Lessons from glucocorticoid-induced osteoporosis
Pia Rosgaard Jensen et al.
BONE (2015)
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Barbara C. Silva et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism
Natalie E. Cusano et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2015)
Osteoblast Recruitment Routes in Human Cancellous Bone Remodeling
Helene B. Kristensen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment
Yanfei L. Ma et al.
BONE (2014)
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Teriparatide Increases Strength of the Peripheral Skeleton in Premenopausal Women With Idiopathic Osteoporosis: A Pilot HR-pQCT Study
Kyle K. Nishiyama et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Understanding Coupling between Bone Resorption and Formation Are Reversal Cells the Missing Link?
Thomas L. Andersen et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
PTH(1-84) Replacement Therapy in Hypoparathyroidism: A Randomized Controlled Trial on Pharmacokinetic and Dynamic Effects After 6 Months of Treatment
Tanja Sikjaer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT
Stinus Hansen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Therapy of Hypoparathyroidism with PTH(1-84): A Prospective Four-Year Investigation of Efficacy and Safety
Natalie E. Cusano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS)
A. L. Schafer et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs as Therapies for Osteoporosis
Marilyn Augustine et al.
CURRENT OSTEOPOROSIS REPORTS (2013)
Changes in 3-Dimensional Bone Structure Indices in Hypoparathyroid Patients Treated With PTH(1-84): A Randomized Controlled Study
Tanja Sikjaer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure
Rachel I. Gafni et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Synthetic Human Parathyroid Hormone 1-34 Replacement Therapy: A Randomized Crossover Trial Comparing Pump Versus Injections in the Treatment of Chronic Hypoparathyroidism
Karen K. Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Effect of Adding PTH(1-84) to Conventional Treatment of Hypoparathyroidism: A Randomized, Placebo-Controlled Study
Tanja Sikjaer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
PTH(1-84) Administration Reverses Abnormal Bone-Remodeling Dynamics and Structure in Hypoparathyroidism
Mishaela R. Rubin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis
H. M. Macdonald et al.
OSTEOPOROSIS INTERNATIONAL (2011)
G protein and its signaling pathway in bone development and disease
Mengrui Wu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
Joel S. Finkelstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Long-Term Treatment of 12 Children with Chronic Hypoparathyroidism: A Randomized Trial Comparing Synthetic Human Parathyroid Hormone 1-34 versus Calcitriol and Calcium
Karen K. Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
R. R. Recker et al.
BONE (2009)
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Sarah J. Glover et al.
BONE (2009)
Hip Fractures and the Contribution of Cortical Versus Trabecular Bone to Femoral Neck Strength
Gerold Holzer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effects of Teriparatide Retreatment in Osteoporotic Men and Women
Joel S. Finkelstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Hypoparathyroidism
Dolores Shoback
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis - A randomized trial
Susan L. Greenspan et al.
ANNALS OF INTERNAL MEDICINE (2007)
Long-term treatment of hypoparathyroidism:: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium
KK Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure
CA Frolik et al.
BONE (2003)
Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
JR Zanchetta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
E Orwoll et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation
V Everts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study
DW Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: Results of a randomized controlled clinical trial
NE Lane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis
AB Hodsman et al.
BONE (2000)
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
ES Kurland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)